Results
|
281.
|
|
|
282.
|
|
|
283.
|
|
|
284.
|
|
|
285.
|
|
|
286.
|
|
|
287.
|
|
|
288.
|
|
|
289.
|
|
|
290.
|
|
|
291.
|
|
|
292.
|
|
|
293.
|
Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib. [electronic resource] by
- Demircan, Nazım C
- Alan, Özkan
- Başoğlu Tüylü, Tuğba
- Akın Telli, Tuğba
- Arıkan, Rukiye
- Çiçek, Furkan C
- Ercelep, Özlem
- Öztürk, Mehmet A
- Alsan Çetin, İlknur
- Ergelen, Rabia
- Tinay, İlker
- Akgül Babacan, Nalan
- Kaya, Serap
- Dane, Faysal
- Yumuk, Perran F
Producer: 20201027
In:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 26
Availability: No items available.
|
|
294.
|
|
|
295.
|
|
|
296.
|
|
|
297.
|
|
|
298.
|
|
|
299.
|
|
|
300.
|
|